We talk about social anxiety like it’s just shyness with a clinical name. But for some patients, it’s life-halting.

Your patient has a new partner. But she doesn’t seem happy.

We’re trained to treat mental illness—not to navigate the courtroom.

Her business was failing and her marriage was falling apart. She wanted to OD on her insulin.

We reviewed Psymatik in The Carlat Psychiatry Report this month, as part of our occasional coverage on how AI and digital tools are changing the way we prescribe.

We use medications for reasons that don’t match their names. That’s why some clinicians are turning to Neuroscience-Based Nomenclature (NbN)—a system that classifies meds by mechanism instead of indication.

You start a medication. The patient feels better in two weeks. You think: “Finally. This one works.” But six weeks later, the magic’s gone.